Parinandi N L, Roy S, Shi S, Cummings R J, Morris A J, Garcia J G, Natarajan V
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Asthma and Allergy Center, Johns Hopkins University, 5501 Bayview Circle, Baltimore, MD 21224, USA.
Arch Biochem Biophys. 2001 Dec 15;396(2):231-43. doi: 10.1006/abbi.2001.2609.
We have shown earlier that oxidant-induced activation of phospholipase D (PLD) in vascular endothelial cells (ECs) is regulated by protein tyrosine kinases. To further understand the regulation of oxidant-induced PLD activation, we investigated the role of Src kinase. Treatment of bovine pulmonary artery ECs (BPAECs) with a model oxidant, diperoxovanadate (DPV), at 5 microM concentration, for 30 min, stimulated PLD activity (four- to eightfold), which was attenuated by tyrosine kinase inhibitors and by Src kinase-specific inhibitors PP-1 and PP-2, in a dose- and time-dependent fashion. Furthermore, BPAECs exposed to DPV (5 microM) for 2 min showed activation of Src kinase as observed by increased tyrosine phosphorylation and autophosphorylation in Src immunoprecipitates, which was attenuated by PP-2. Src immunoprecipitates of cell lysates from control BPAECs exhibited PLD activity in cell-free preparations, which was Arf- and Rho-sensitive and was enhanced at 2 min of DPV (5 microM) treatment. Also, Western blots of Src immunoprecipitates of control cells revealed the presence of PLD(1) and PLD(2), suggesting the association of PLD with Src kinase under basal conditions. However, exposure of cells to DPV (5 microM) for 2 min enhanced the association of PLD(2) but not PLD(1) with Src. Western blotting of immunoprecipitates of PLD(1) and PLD(2) isoforms of control BPAECs revealed the presence of Src under basal conditions and exposure of cells to DPV (5 microM) for 2 min enhanced the association of PLD(2) with Src in PLD(2) immunoprecipitates. Transient expression of a dominant negative mutant of Src in BPAECs attenuated DPV- but not TPA-induced PLD activation. In cell-free preparations, Src did not phosphorylate either PLD(1) or PLD(2) compared to protein kinase Calpha or p38 mitogen-activated protein kinase. These data show for the first time a direct association of Src with PLD in ECs and regulation of PLD in intact cells.
我们之前已经表明,血管内皮细胞(ECs)中氧化剂诱导的磷脂酶D(PLD)激活受蛋白酪氨酸激酶调控。为了进一步了解氧化剂诱导的PLD激活的调控机制,我们研究了Src激酶的作用。用5微摩尔浓度的模型氧化剂双过氧钒酸盐(DPV)处理牛肺动脉内皮细胞(BPAECs)30分钟,可刺激PLD活性(提高4至8倍),酪氨酸激酶抑制剂以及Src激酶特异性抑制剂PP - 1和PP - 2可呈剂量和时间依赖性地减弱这种刺激作用。此外,暴露于DPV(5微摩尔)2分钟的BPAECs显示Src激酶激活,这可通过Src免疫沉淀物中酪氨酸磷酸化和自磷酸化增加观察到,而PP - 2可减弱这种激活。来自对照BPAECs的细胞裂解物的Src免疫沉淀物在无细胞制剂中表现出PLD活性,这种活性对Arf和Rho敏感,并且在DPV(5微摩尔)处理2分钟时增强。同样,对照细胞的Src免疫沉淀物的蛋白质印迹显示存在PLD(1)和PLD(2),表明在基础条件下PLD与Src激酶相关。然而,细胞暴露于DPV(5微摩尔)2分钟增强了PLD(2)而非PLD(1)与Src的结合。对照BPAECs的PLD(1)和PLD(2)同工型免疫沉淀物的蛋白质印迹显示在基础条件下存在Src,并且细胞暴露于DPV(5微摩尔)2分钟增强了PLD(2)免疫沉淀物中PLD(2)与Src的结合。在BPAECs中瞬时表达Src的显性负性突变体减弱了DPV诱导而非佛波酯(TPA)诱导的PLD激活。在无细胞制剂中,与蛋白激酶Cα或p38丝裂原活化蛋白激酶相比,Src不会使PLD(1)或PLD(2)磷酸化。这些数据首次表明在ECs中Src与PLD直接相关以及在完整细胞中对PLD的调控。